Search

Stryker Corp

Slēgts

SektorsVeselības aprūpe

273.92 -2.02

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

273.92

Max

276.83

Galvenie mērījumi

By Trading Economics

Ienākumi

531M

1.3B

Pārdošana

569M

6.6B

P/E

Sektora vidējais

29.24

56.432

EPS

3.69

Dividenžu ienesīgums

1.26

Peļņas marža

19.366

Darbinieki

56,000

EBITDA

266M

1.6B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+34.94% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

1.26%

2.27%

Nākamie ieņēmumi

2026. g. 29. okt.

Nākamais dividenžu datums

2026. g. 30. okt.

Nākamais Ex dividenžu datums

2026. g. 29. sept.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-21B

108B

Iepriekšējā atvēršanas cena

275.94

Iepriekšējā slēgšanas cena

273.92

Ziņu noskaņojums

By Acuity

56%

44%

262 / 339 Rangs Healthcare

Stryker Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 18. sept. 23:02 UTC

Stryker Corp is seeing a notable increase in after-market trading, gaining ground since Friday's close and reflecting significant upward movement.

2026. g. 17. sept. 20:07 UTC

News

Stryker Corporation's stock fell amid scrutiny over ongoing manufacturing issues, resulting in a loss of over $10 billion in market capitalization.

2026. g. 16. sept. 23:01 UTC

Correlated Moves

Stryker Corp is experiencing a modest decline in after-market trading, retracing significantly after peaking post-close amid broader market fluctuations.

2026. g. 15. sept. 23:21 UTC

Stryker Corp shares are lower in after-market hours, reflecting broader market trends as rising Treasury yields pressure equities amid rate hike expectations.

2026. g. 14. sept. 20:03 UTC

News

Stryker Corp shares are higher today, responding positively despite Citigroup lowering its price target to $360 while maintaining a "buy" rating.

2026. g. 11. sept. 22:01 UTC

Stryker Corp shares are lower in after-market trading. The decline follows a drop in the Michigan Consumer Sentiment Index, reflecting consumer concerns about inflation.

2026. g. 10. sept. 20:03 UTC

Macro Event
News

Stryker Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in share price amid ongoing manufacturing issues.

2026. g. 9. sept. 20:07 UTC

News

Stryker Corp shares are declining amid a securities fraud investigation and a lowered price target of $348 from Wells Fargo.

2026. g. 8. sept. 23:06 UTC

Stryker Corp. shares are higher in after-market trading, following seven consecutive sessions of declines amid rising expectations for a Federal Reserve interest rate hike.

2026. g. 4. sept. 20:07 UTC

Stryker Corp shares are lower today, marking six consecutive sessions of declines. The stock remains significantly below its 20-day moving average.

2026. g. 3. sept. 19:36 UTC

Stryker Corp shares are lower today, continuing a four-session decline. The stock remains significantly below its 20-day moving average amid broader market trends.

2026. g. 2. sept. 22:16 UTC

Shares of Stryker Corp are trading higher in after-market hours, following a session peak. Broader market concerns include rising oil prices and inflation risks.

2026. g. 1. sept. 23:26 UTC

Stryker Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. Rising oil prices are noted as broader market context.

2026. g. 31. aug. 20:03 UTC

Stryker Corp shares are lower amid broader market pressures from Jackson Hole remarks on inflation and potential interest rate hikes. No specific company news identified.

2026. g. 28. aug. 20:02 UTC

Stryker Corp shares are higher today, continuing an upward trend since Thursday's close, despite earlier session declines. No specific news was identified.

2026. g. 27. aug. 21:02 UTC

Correlated Moves

Shares rise in after-market hours, rebounding from three lower sessions.

2026. g. 26. aug. 20:08 UTC

Stryker Corp shares are lower as inflation data shows consumer prices rose more than expected, influencing broader market trends. No specific company news was identified.

2026. g. 25. aug. 23:36 UTC

Stryker Corp shares are lower in after-market trading, positioned below their 20-day moving average and near the lower end of their one-month range.

2026. g. 24. aug. 20:06 UTC

News

Stryker Corp received a $100 million contract modification from the U.S. Department of Defense, but shares are trading lower amid rising oil prices and geopolitical tensions.

2026. g. 21. aug. 19:53 UTC

News

Stryker Corp shares are higher as insider selling by Ronda E. Stryker is offset by strong financial metrics, including a 9.42% revenue growth rate.

2026. g. 20. aug. 20:02 UTC

News

Stryker Corp shares are lower today, reflecting broader market pressures following Walmart's disappointing earnings and a 3.40% decline since Wednesday.

2026. g. 19. aug. 20:02 UTC

News

Stryker Corp received a $100 million contract modification from the Defense Logistics Agency, boosting shares during Wednesday's trading session.

2026. g. 18. aug. 19:35 UTC

Stryker Corp is advancing today, driven by gains in the Health Care Equipment sub-sector. Earlier, shares peaked before pulling back slightly.

2026. g. 17. aug. 19:51 UTC

Stryker Corp shares are lower today, continuing a decline influenced by weakness in the Health Care Equipment sector. No specific news was identified.

2026. g. 14. aug. 19:56 UTC

Stryker Corp shares are lower amid broader market sentiment following a surprise drop in U.S. retail sales for July. The stock has seen lower closes recently.

2026. g. 13. aug. 20:06 UTC

News

Stryker Corp shares declined following Wolfe Research's downgrade to Peer Perform, citing a challenging outlook and tempered growth expectations for the second half of the year.

2026. g. 12. aug. 19:16 UTC

Stryker Corp. shares are lower amid geopolitical tensions and rising crude oil prices, despite remaining above their 20-day moving average.

2026. g. 11. aug. 23:26 UTC

Stryker Corp. shares declined in after-market trading, reflecting broader market trends amid cautious investor sentiment and lower oil prices.

2026. g. 10. aug. 23:06 UTC

Stryker Corp shares are higher in after-market trading, continuing a trend above the 20-day moving average after three consecutive sessions of gains.

2026. g. 7. aug. 20:06 UTC

Stryker Corp shares are higher, supported by declining Treasury yields after July's unemployment rate fell to 4.1%. Earlier, the stock pulled back from session lows.

Salīdzinājums

Cenas izmaiņa

Stryker Corp Prognoze

Cenas mērķis

By TipRanks

34.94% augšup

Prognoze 12 mēnešiem

Vidējais 371.235 USD  34.94%

Augstākais 420 USD

Zemākais 317 USD

Pamatojoties uz 18 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Stryker Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

18 ratings

16

Pirkt

2

Turēt

0

Pārdot

Noskaņojums

By Acuity

262 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.